Hamilton James C sold ARWR
January 5, 2026 · Form 4 insider transaction
Hamilton James C sold 309 shares of Arrowhead Pharmaceuticals, Inc. at $68.00 per share, a transaction worth $21.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
309
Price
$68.00
Total value
$21.0K
InsiderHamilton James C
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 5, 2026
Shares owned after171,958
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.; Partial disposition of shares to satisfy tax withholding obligations.; Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.